Company Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name.
The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand.
It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels.
The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018.
Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 10, 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 600 |
| CEO | Ronald Lombardi |
Contact Details
Address: 660 White Plains Road Tarrytown, New York 10591 United States | |
| Phone | 914 524 6800 |
| Website | prestigebrands.com |
Stock Details
| Ticker Symbol | PBH |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001295947 |
| CUSIP Number | 74112D101 |
| ISIN Number | US74112D1019 |
| Employer ID | 20-1297589 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ronald M. Lombardi CPA | Chairman, President and Chief Executive Officer |
| Christine Sacco CPA | Chief Financial Officer and Chief Operating Officer |
| William C. P'Pool J.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Adel Mekhail | Executive Vice President of Marketing and Sales |
| Jeffrey Zerillo | Senior Vice President of Operations |
| Philip David Terpolilli C.F.A. | Director of Investor Relations |
| Dean Siegal | Director of Communications |
| Mary Beth Fritz | Senior Vice President of Quality and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 27, 2025 | ARS | Filing |
| Jun 27, 2025 | DEF 14A | Other definitive proxy statements |
| May 9, 2025 | 10-K | Annual Report |
| May 8, 2025 | 8-K | Current Report |
| Apr 30, 2025 | SCHEDULE 13G/A | Filing |
| Mar 10, 2025 | 144 | Filing |
| Mar 3, 2025 | 144 | Filing |
| Feb 11, 2025 | 144 | Filing |
| Feb 7, 2025 | SCHEDULE 13G/A | Filing |
| Feb 6, 2025 | 10-Q | Quarterly Report |